Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Deckert

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Pigment Cell & Melanoma Research|October 20, 2010
The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progressionNina Fenouille, Guillaume Robert, Mélanie Tichet, et al.
Plos One|February 13, 2009
Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressivenessKhadija Essafi-Benkhadir, Sébastien Grosso, Alexandre Puissant, et al.
Molecular Cancer Therapeutics|July 2, 2009
Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitorsSébastien Grosso, Alexandre Puissant, Maeva Dufies, et al.
Molecular Cancer Therapeutics|April 29, 2018
Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting TherapiesRobin Didier, Aude Mallavialle, Rania Ben Jouira, et al.
Cancer Research|March 19, 2009
Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrestOlivier Bailet, Nina Fenouille, Patricia Abbe, et al.
Annals of Hematology|February 9, 2025
Novel ETV6::RAPGEF6 fusion gene in chronic eosinophilic leukemia: compiling evidence on the role of IL3 overexpression in tumorigenesisMathilde Iberti, Michael Loschi, Frédérique Keslair, et al.
Immunity|October 22, 2002
ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1Ana Urzainqui, Juan M Serrador, Fernando Viedma, et al.
Cell Reports|October 2, 2025
USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilizationPierric Biber, Alexandrine Carminati, Walaa Mohager, et al.
Oncogenesis|June 13, 2026
Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathwayMargaux Lecacheur, Ilona Berestjuk, Alexandrine Carminati, et al.
Cancer Research|November 25, 2010
Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARCNina Fenouille, Alexandre Puissant, Maeva Dufies, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Pigment Cell & Melanoma Research|October 20, 2010
The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progressionNina Fenouille, Guillaume Robert, Mélanie Tichet, et al.
Plos One|February 13, 2009
Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressivenessKhadija Essafi-Benkhadir, Sébastien Grosso, Alexandre Puissant, et al.
Molecular Cancer Therapeutics|July 2, 2009
Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitorsSébastien Grosso, Alexandre Puissant, Maeva Dufies, et al.
Molecular Cancer Therapeutics|April 29, 2018
Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting TherapiesRobin Didier, Aude Mallavialle, Rania Ben Jouira, et al.
Cancer Research|March 19, 2009
Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrestOlivier Bailet, Nina Fenouille, Patricia Abbe, et al.
Annals of Hematology|February 9, 2025
Novel ETV6::RAPGEF6 fusion gene in chronic eosinophilic leukemia: compiling evidence on the role of IL3 overexpression in tumorigenesisMathilde Iberti, Michael Loschi, Frédérique Keslair, et al.
Immunity|October 22, 2002
ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1Ana Urzainqui, Juan M Serrador, Fernando Viedma, et al.
Cell Reports|October 2, 2025
USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilizationPierric Biber, Alexandrine Carminati, Walaa Mohager, et al.
Oncogenesis|June 13, 2026
Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathwayMargaux Lecacheur, Ilona Berestjuk, Alexandrine Carminati, et al.
Cancer Research|November 25, 2010
Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARCNina Fenouille, Alexandre Puissant, Maeva Dufies, et al.
Pageof 6